A VEGF Trap Inhibits the Beneficial Effect of bFGF on Vasoreactivity in Corporal Tissues of Hypercholesterolemic Rabbits
- 1 September 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 5 (9) , 2069-2078
Abstract
Hypercholesterolemia causes a decrease in normal corporal tissue vasoreactivity in a preclinical model of erectile dysfunction. Previous studies have shown that intracorporal injection (ICI) of basic fibroblast growth factor (bFGF) reverses some of the detrimental vasoreactivity effects of hypercholesterolemia and increases vascular endothelial growth factor (VEGF) expression. We sought to determine whether the beneficial effects of bFGF are VEGF-mediated. A total of 32 New Zealand white rabbits were fed a 1% cholesterol diet for 6 weeks and randomly divided into four groups (N = 8/group). Group 1 received a 2.5 microg bFGF ICI and 2.5 x 10(11) viral particle unit (vpu) of adenovirus encoding beta-galactosidase (Ad beta-gal) ICI, 10 days later. Group 2 received a 2.5 microg bFGF ICI and 2.5 x 10(11) vpu of adenovirus encoding soluble VEGF receptor (VEGFR) (AdsVEGFR, a VEGF trap) ICI, 10 days later. Group 3 received phosphate buffered saline solution (PBS) ICI and 2.5 x 10(11) vpu Ad beta-gal ICI, 10 days later. Group 4 received PBS ICI and 2.5 x 10(11) vpu AdsVEGFR ICI, 10 days later. The corpus cavernosum was harvested for vasoreactivity studies 10 days post viral injection. The effective dose of 50% maximum relaxation was determined. VEGF levels were assessed by enzyme-linked immunosorbent assay. Total and phosphorylated Akt and endothelial nitric oxide were analyzed by Western blot. Endothelium-dependent vasoreactivity was significantly greater in Group 1 vs. all other groups. The VEGF trap eliminated the beneficial effects of bFGF on endothelium-dependent vasoreactivity and decreased Akt and nitric oxide phosphorylation. These data demonstrate that VEGF activity contributes much of the therapeutic modulation of bFGF-mediated vasoreactivity in corporal tissue.Keywords
This publication has 24 references indexed in Scilit:
- A Mouse Model of Hypercholesterolemia-Induced Erectile DysfunctionThe Journal of Sexual Medicine, 2007
- Heme Oxygenase vs. Nitric Oxide Synthase in Signaling Mediating Sildenafil Citrate ActionThe Journal of Sexual Medicine, 2007
- Antisense and Short Hairpin RNA (shRNA) Constructs Targeting PIN (Protein Inhibitor of NOS) Ameliorate Aging-Related Erectile Dysfunction in the RatThe Journal of Sexual Medicine, 2007
- Altered Penile Vascular Reactivity and Erection in the Zucker Obese-Diabetic RatThe Journal of Sexual Medicine, 2007
- Vasculogenic erectile dysfunction: beyond the haemodynamic changesBJU International, 2005
- DECREASES IN CORPOREAL VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION PRECEDE VASOREACTIVITY CHANGES IN CHOLESTEROL FED RABBITSJournal of Urology, 2005
- Phosphorylated Endothelial Nitric Oxide Synthase Mediates Vascular Endothelial Growth Factor-Induced Penile Erection1Biology of Reproduction, 2004
- Vasculogenic Erectile Dysfunction: Newer Therapeutic StrategiesJournal of Urology, 2003
- bFGF restores endothelium-dependent responses of hypercholesterolemic rabbit thoracic aortaAmerican Journal of Physiology-Heart and Circulatory Physiology, 1997
- Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic NeurotransmissionNew England Journal of Medicine, 1992